IN8bio’s Phase 1 AML da­ta; Lay­offs at Q32 Bio and Third Har­mon­ic

Plus, news about Arv­inas and In­vizyne Tech­nolo­gies:

IN8bio’s Phase 1 da­ta in acute myeloid leukemia: In an in­ves­ti­ga­tor-spon­sored study, all nine pa­tients who re­ceived the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER